Works by Quintela-Fandino, Miguel

Results: 25

p27<sup>Kip1</sup> V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancer.

Published in:

JNCI Cancer Spectrum, 2023, v. 7, n. 2, p. 1, doi. 10.1093/jncics/pkad014

By:

Mouron, Silvana;
Bueno, Maria J;
Muñoz, Manuel;
Torres, Raul;
Rodríguez, Sandra;
Apala, Juan V;
Silva, Jorge;
Sánchez-Bayona, Rodrigo;
Manso, Luis;
Guerra, Juan;
Rodriguez-Lajusticia, Laura;
Malon, Diego;
Malumbres, Marcos;
Quintela-Fandino, Miguel

Publication type:

Article

Influence of Music Therapy on the Improvement of Perceived Well-Being Indices in Women with Breast Cancer Undergoing Hormonal Treatment.

Published in:

American Journal of Health Education, 2024, v. 55, n. 5, p. 315, doi. 10.1080/19325037.2024.2338458

By:

Fernández-Company, José Fernando;
Quintela-Fandino, Miguel;
Sandes, Vikrampal;
García-Rodríguez, María

Publication type:

Article

Emerging role of Fatty acid synthase in tumor initiation: implications for cancer prevention.

Published in:

2020

By:

Bueno, Maria J.;
Quintela-Fandino, Miguel

Publication type:

Opinion

miR-203 drives breast cancer cell differentiation.

Published in:

Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01690-9

By:

Martínez-Illescas, Nuria G.;
Leal, Silvia;
González, Patricia;
Graña-Castro, Osvaldo;
Muñoz-Oliveira, Juan José;
Cortés-Peña, Alfonso;
Gómez-Gil, María;
Vega, Zaira;
Neva, Verónica;
Romero, Andrea;
Quintela-Fandino, Miguel;
Ciruelos, Eva;
Sanz, Consuelo;
Aragón, Sofía;
Sotolongo, Leisy;
Jiménez, Sara;
Caleiras, Eduardo;
Mulero, Francisca;
Sánchez, Cristina;
Malumbres, Marcos

Publication type:

Article

Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation.

Published in:

Clinical & Translational Oncology, 2024, v. 26, n. 5, p. 1273, doi. 10.1007/s12094-023-03329-9

By:

Bueno, Maria Jose;
Mouron, Silvana;
Caleiras, Eduardo;
Martínez, Mario;
Manso, Luis;
Colomer, Ramón;
Quintela-Fandino, Miguel

Publication type:

Article

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.

Published in:

Clinical & Translational Oncology, 2023, v. 25, n. 4, p. 1124, doi. 10.1007/s12094-022-03006-3

By:

Jimeno, Rebeca;
Mouron, Silvana;
Salgado, Roberto;
Loi, Sherene;
Pérez-Mies, Belén;
Sánchez-Bayona, Rodrigo;
Manso, Luis;
Martínez, Mario;
Garrido-García, Ana;
Serrano-Pardo, Rosario;
Colomer, Ramón;
Quintela-Fandino, Miguel

Publication type:

Article

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Published in:

Cancer (0008543X), 2006, v. 106, n. 1, p. 106, doi. 10.1002/cncr.21579

By:

Ricardo Hitt;
Maria L. Amador;
Miguel Quintela‐Fandino;
Antonio Jimeno;
Olga del Val;
Susana Hernando;
Hernan Cortes‐Funes

Publication type:

Article

[6]-Gingerol-Derived Semi-Synthetic Compound SSi6 Inhibits Tumor Growth and Metastatic Dissemination in Triple-Negative Breast Cancer Xenograft Models.

Published in:

Cancers, 2021, v. 13, n. 12, p. 2855, doi. 10.3390/cancers13122855

By:

Luna-Dulcey, Liany;
Almada da Silva, James;
Jimenez-Renard, Veronica;
Caleiras, Eduardo;
Mouron, Silvana;
Quintela-Fandino, Miguel;
Cominetti, Marcia R.

Publication type:

Article

Targeting cytoskeleton reorganisation as antimetastatic treatment.

Published in:

Clinical & Translational Oncology, 2010, v. 12, n. 10, p. 662, doi. 10.1007/s12094-010-0575-8

By:

Quintela-Fandino, Miguel;
González-Martín, Antonio;
Colomer, Ramon

Publication type:

Article

The impact of a high fat diet and platelet activation on pre-metastatic niche formation.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-57938-9

By:

Hergueta-Redondo, Marta;
Sánchez-Redondo, Sara;
Hurtado, Begoña;
Santos, Vanesa;
Pérez-Martínez, Manuel;
Ximénez- Embún, Pilar;
McDowell, Sheri A. C.;
Mazariegos, Marina S.;
Mata, Gadea;
Torres-Ruiz, Raúl;
Rodríguez-Perales, Sandra;
Martínez, Lola;
Graña-Castro, Osvaldo;
Megias, Diego;
Quail, Daniela;
Quintela-Fandino, Miguel;
Peinado, Héctor

Publication type:

Article

RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer.

Published in:

EMBO Molecular Medicine, 2023, v. 15, n. 4, p. 1, doi. 10.15252/emmm.202216715

By:

Ciscar, Marina;
Trinidad, Eva M;
Perez‐Chacon, Gema;
Alsaleem, Mansour;
Jimenez, Maria;
Jimenez‐Santos, Maria J;
Perez‐Montoyo, Hector;
Sanz‐Moreno, Adrian;
Vethencourt, Andrea;
Toss, Michael;
Petit, Anna;
Soler‐Monso, Maria T;
Lopez, Victor;
Gomez‐Miragaya, Jorge;
Gomez‐Aleza, Clara;
Dobrolecki, Lacey E;
Lewis, Michael T;
Bruna, Alejandra;
Mouron, Silvana;
Quintela‐Fandino, Miguel

Publication type:

Article

Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance.

Published in:

PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0155840

By:

Manso, Luis;
Mourón, Silvana;
Tress, Michael;
Gómez-López, Gonzalo;
Morente, Manuel;
Ciruelos, Eva;
Rubio-Camarillo, Miriam;
Rodriguez-Peralto, Jose Luis;
Pujana, Miguel A.;
Pisano, David G.;
Quintela-Fandino, Miguel

Publication type:

Article

MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia.

Published in:

Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54901-9

By:

Morales, María Luz;
Arenas, Alicia;
Ortiz-Ruiz, Alejandra;
Leivas, Alejandra;
Rapado, Inmaculada;
Rodríguez-García, Alba;
Castro, Nerea;
Zagorac, Ivana;
Quintela-Fandino, Miguel;
Gómez-López, Gonzalo;
Gallardo, Miguel;
Ayala, Rosa;
Linares, María;
Martínez-López, Joaquín

Publication type:

Article

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells.

Published in:

Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13028-1

By:

Bueno, Maria J.;
Jimenez-Renard, Veronica;
Samino, Sara;
Capellades, Jordi;
Junza, Alejandra;
López-Rodríguez, María Luz;
Garcia-Carceles, Javier;
Lopez-Fabuel, Irene;
Bolaños, Juan P.;
Chandel, Navdeep S.;
Yanes, Oscar;
Colomer, Ramon;
Quintela-Fandino, Miguel

Publication type:

Article

Correction: Applicability of epigenetic age models to next-generation methylation arrays.

Published in:

2024

By:

Garma, Leonardo D.;
Quintela-Fandino, Miguel

Publication type:

Correction Notice

Applicability of epigenetic age models to next-generation methylation arrays.

Published in:

Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01387-4

By:

Garma, Leonardo D.;
Quintela-Fandino, Miguel

Publication type:

Article

Applicability of epigenetic age models to next-generation methylation arrays.

Published in:

Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01387-4

By:

Garma, Leonardo D.;
Quintela-Fandino, Miguel

Publication type:

Article

Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach.

Published in:

2017

By:

Bueno, Maria J;
Mouron, Silvana;
Quintela-Fandino, Miguel

Publication type:

journal article

FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.

Published in:

2021

By:

Mouron, Silvana;
Manso, Luis;
Caleiras, Eduardo;
Rodriguez-Peralto, Jose L.;
Rueda, Oscar M.;
Caldas, Carlos;
Colomer, Ramon;
Quintela-Fandino, Miguel;
Bueno, Maria J.

Publication type:

journal article

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial.

Published in:

2020

By:

Quintela-Fandino, Miguel;
Holgado, Esther;
Manso, Luis;
Morales, Serafin;
Bermejo, Begoña;
Colomer, Ramon;
Apala, Juan V.;
Blanco, Raquel;
Muñoz, Manuel;
Caleiras, Eduardo;
Iranzo, Vega;
Martinez, Mario;
Dominguez, Orlando;
Hornedo, Javier;
Gonzalez-Cortijo, Lucia;
Cortes, Javier;
Gasol Cudos, Ariadna;
Malon, Diego;
Lopez-Alonso, Antonio;
Moreno-Ortíz, María C.

Publication type:

journal article

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition.

Published in:

2019

By:

Quintela-Fandino, Miguel;
Apala, Juan V.;
Malon, Diego;
Mouron, Silvana;
Hornedo, Javier;
Gonzalez-Cortijo, Lucia;
Colomer, Ramon;
Guerra, Juan

Publication type:

journal article

Mitochondrial Inhibition: a Treatment Strategy in Cancer?

Published in:

Current Oncology Reports, 2021, v. 23, n. 4, p. 1, doi. 10.1007/s11912-021-01033-x

By:

Bueno, Maria J.;
Ruiz-Sepulveda, Jose L.;
Quintela-Fandino, Miguel

Publication type:

Article

Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells.

Published in:

Molecular Oncology, 2022, v. 16, n. 1, p. 148, doi. 10.1002/1878-0261.13083

By:

Hühn, Daniela;
Martí‐Rodrigo, Pablo;
Mouron, Silvana;
Hansel, Catherine;
Tschapalda, Kirsten;
Porebski, Bartlomiej;
Häggblad, Maria;
Lidemalm, Louise;
Quintela‐Fandino, Miguel;
Carreras‐Puigvert, Jordi;
Fernandez‐Capetillo, Oscar

Publication type:

Article

Monitoring vascular normalization induced by antiangiogenic treatment with 18F-fluoromisonidazole-PET.

Published in:

Molecular Oncology, 2016, v. 10, n. 5, p. 704, doi. 10.1016/j.molonc.2015.12.011

By:

Hernández-Agudo, Elena;
Mondejar, Tamara;
Soto-Montenegro, Maria Luisa;
Megías, Diego;
Mouron, Silvana;
Sanchez, Jesus;
Hidalgo, Manuel;
Lopez-Casas, Pedro Pablo;
Mulero, Francisca;
Desco, Manuel;
Quintela-Fandino, Miguel

Publication type:

Article

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: Results of the CNIO-BR002 phase I-trial.

Published in:

Molecular Oncology, 2014, v. 8, n. 8, p. 1719, doi. 10.1016/j.molonc.2014.07.005

By:

Quintela-Fandino, Miguel;
Bueno, Maria J.;
Lombardia, Luis;
Gil, Marta;
Gonzalez-Martin, Antonio;
Marquez, Raul;
Bratos, Raquel;
Guerra, Juan;
Tan, Eugene;
Lopez, Antonio;
Colomer, Ramon;
Salazar, Ramon

Publication type:

Article